S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea flag South Korea · Delayed Price · Currency is KRW
20,550
-200 (-0.96%)
At close: Jul 6, 2026

S.Biomedics Revenue

S.Biomedics had revenue of 4.40B KRW in the quarter ending March 31, 2026, a decrease of -1.45%. This brings the company's revenue in the last twelve months to 16.48B, up 5.73% year-over-year. In the year 2025, S.Biomedics had annual revenue of 16.55B with 20.49% growth.

Revenue (ttm)
16.48B
Revenue Growth
+5.73%
P/S Ratio
15.22
Revenue / Employee
n/a
Employees
n/a
Market Cap
250.80B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202516.55B2.81B20.49%
Dec 31, 202413.73B625.65M4.77%
Dec 31, 202313.11B995.73M8.22%
Dec 31, 202212.11B3.24B36.58%
Dec 31, 20218.87B3.55B66.72%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
HansBiomed110.50B
NIBEC32.34B
Genome & Company24.02B
Bio Solution15.82B
Kangstem Biotech3.42B
Y-Biologics2.79B
IntoCell2.47B
curacle co.,ltd.1.06B
Revenue Rankings